Selectively T cell phosphorylation activation of azvudine in the thymus tissue with immune protection effect
Thymus is the important immune organ, responsible for T cell development and differentiation. The lower circulating T counts have been observed in patients who died from COVID-19 compared with survivors. Azvudine, also known as FNC, is a thymus-homing anti-SARS-CoV-2 drug in treating COVID-19 patien...
Saved in:
Main Authors: | Ning Sheng (Author), Rui Li (Author), Yang Li (Author), Zhe Wang (Author), Lulu Wang (Author), Yuhuan Li (Author), Jinlan Zhang (Author), Jiandong Jiang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Azvudine reduces the in-hospital mortality of COVID-19 patients: A retrospective cohort study
by: Kaican Zong, et al.
Published: (2023) -
Elevated INR in a COVID-19 patient after concomitant administration of azvudine and anticoagulants
by: Xi Zhang, et al.
Published: (2023) -
Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study
by: Wei Yang, et al.
Published: (2024) -
Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway
by: Congyu Ma, et al.
Published: (2024) -
Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China
by: Nan Shang, et al.
Published: (2024)